Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617
This examiner grants 26% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16804177 | STORAGE-STABLE READY-TO-USE INJECTABLE FORMULATIONS OF FOSAPREPITANT DIMEGLUMINE | Final Rejection | CITIBANK, N.A. |
| 15621627 | Glycosaminoglycan-Based Materials as an Engineered Biocompatible Cellular Matrix | Final Rejection | Purdue Research Foundation |
| 18940147 | FAST DISSOLVING SOFTGEL CAPSULES | Final Rejection | R.P. SCHERER TECHNOLOGIES, LLC |
| 16753567 | IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17576141 | MICRONEEDLE ARRAYS FOR CANCER THERAPY APPLICATIONS | Non-Final OA | Carnegie Mellon University |
| 18151932 | IMPREGNATED COSMETIC ARTICLE WITH FIBERS AND SCREEN NET | Non-Final OA | L'OREAL |
| 18001411 | 3D LASER SINTERING PROCESSES FOR IMPROVED DRUG DELIVERY | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18209618 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VENOM RELATED POISONING | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 18314808 | COMPOSITION FOR PENETRATING SUGAR BASED DELIVERY SYSTEM | Non-Final OA | Evonik Operations GmbH |
| 17697941 | LIPID-BASED NANOPARTICLE DELIVERY SYSTEM FOR HYDROPHILIC CHARGED COMPOUND | Non-Final OA | National Taiwan University |
| 18590579 | CONTACT LENS INCLUDING NANOPORES | Non-Final OA | Iowa State University Research Foundation, Inc. |
| 18261290 | LUBRICANT | Non-Final OA | RECKITT BENCKISER HEALTH LIMITED |
| 17759863 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | Non-Final OA | CORTEVA AGRISCIENCE LLC |
| 18765884 | COMPOSITIONS FOR THE TREATMENT OF INFECTIONS IN FEET | Final Rejection | Therazure LLC |
| 17792653 | Nitro-Fatty Acid-Containing Microbubbles and Uses Therefor | Non-Final OA | University of Pittsburgh-Of the Commonwealth System of Higher Education |
| 18558081 | ANTIMICROBIAL PARTICLE DISPERSION | Non-Final OA | MITSUBISHI PENCIL COMPANY, LIMITED |
| 18358109 | Hemostatic Materials Based on Aldehyde-Functional Polysaccharides | Non-Final OA | Ethicon, Inc. |
| 18613465 | ANTIMICROBIAL COMPOSITIONS | Final Rejection | GOJO Industries, Inc. |
| 17758205 | SYSTEMS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT BY DIRECT INJECTION OF A TARGETED POPULATION OF CELLS | Non-Final OA | Privo Technologies, Inc. |
| 18556532 | INSECT CONTROL COMPOSITION | Non-Final OA | Reckitt & Colman (Overseas) Hygiene Home Limited |
| 18513133 | COMPOSITION FOR IMPROVING SKIN CONDITIONS | Non-Final OA | NEOPHARM CO., LTD. |
| 17928065 | TREATMENT OF INFECTIONS | Final Rejection | ACT Therapeutics Ltd |
| 18279138 | AGROCHEMICAL ADJUVANTS FROM STACHYBOTRYS CHARTARUM | Non-Final OA | Croda, Inc. |
| 17918956 | Antimicrobial silver coordination complexes | Final Rejection | Penta Science Industries Holding B.V. |
| 18361142 | ORALLY DISINTEGRATING PALATABLE FORMULATIONS OF DROTAVERINE AND METHOD OF PREPARATION THEREOF | Non-Final OA | Sushma Paul BERLIA |
| 18223148 | ORAL DELIVERY SYSTEMS BASED ON IN SITU FORMING PROTEIN/POLYSACCHARIDE COACERVATES | Final Rejection | 9286-3620 Québec, Inc. |
| 18270361 | TEMPLATE DIRECTED IMMUNOMODULATION FOR CANCER THERAPY | Non-Final OA | Transcode Therapeutics, Inc. |
| 18327740 | METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER | Non-Final OA | Curemark, LLC |
| 17780986 | NANOSTRUCTURED DRUG DELIVERY SYSTEM AS A MULTIFUNCTIONAL PLATFORM FOR THERAPY | Non-Final OA | UNIVERSIDADE DE COIMBRA |
| 18251839 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Non-Final OA | NeOnc Technologies, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy